{"transactions":[{"id":2079839,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-12-20T20:01:10.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":19688,"price":1.1719,"value":23072.3672,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":35546,"source":{"system":"sec-edgar","filing":"0001104659-22-128768","document":"tm2233089-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465922128768/tm2233089-3_4seq1.xml","form_type":"4"}},{"id":2100081,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-12-01T19:53:45.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This filing amends the Form 4, filed on July 15, 2021 by Mr. Alkon to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended."}],"balance_after":55234,"source":{"system":"sec-edgar","filing":"0001104659-22-123807","document":"tm2231816-7_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465922123807/tm2231816-7_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-07-15"}},{"id":2100080,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T19:49:08.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This filing amends the Form 4, filed on November 17, 2022 by Mr. Alkon to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-22-123800","document":"tm2231816-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465922123800/tm2231816-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-11-17"}},{"id":2112225,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T16:02:27.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":112000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001104659-22-119879","document":"tm2230820-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465922119879/tm2230820-4_4seq1.xml","form_type":"4"}},{"id":2633191,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-15T18:05:01.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 80,000 restricted stock units granted on July 13, 2021 (the \"Grant Date\") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date."}],"balance_after":91484,"source":{"system":"sec-edgar","filing":"0001104659-21-092713","document":"tm2122331-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465921092713/tm2122331-2_4seq1.xml","form_type":"4"}},{"id":2666348,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-16T13:01:35.000Z","date":"2021-06-14","kind":"purchase","acquired":true,"shares":10000,"price":8.26,"value":82600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.19 to $8.35, inclusive. The reporting person undertakes to provide to Synaptogenix, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":11484,"source":{"system":"sec-edgar","filing":"0001104659-21-081898","document":"tm2119874d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465921081898/tm2119874d2_4.xml","form_type":"4"}},{"id":2958641,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:39.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.972,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-132155","document":"tm2037705d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920132155/tm2037705d7_4seq1.xml","form_type":"4"}},{"id":2958640,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:39.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":3.93,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-20-132155","document":"tm2037705d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920132155/tm2037705d7_4seq1.xml","form_type":"4"}},{"id":2958639,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:39.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":167000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":19.62,"underlying":"Common Stock","underlying_shares":167000},"source":{"system":"sec-edgar","filing":"0001104659-20-132155","document":"tm2037705d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920132155/tm2037705d7_4seq1.xml","form_type":"4"}},{"id":2958638,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:39.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":124274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":10.56,"underlying":"Common Stock","underlying_shares":124274},"source":{"system":"sec-edgar","filing":"0001104659-20-132155","document":"tm2037705d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920132155/tm2037705d7_4seq1.xml","form_type":"4"}},{"id":2958637,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:39.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":5469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":56,"underlying":"Common Stock","underlying_shares":5469},"source":{"system":"sec-edgar","filing":"0001104659-20-132155","document":"tm2037705d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920132155/tm2037705d7_4seq1.xml","form_type":"4"}},{"id":2958636,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-03T21:41:39.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":29688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the common stock was disposed of as follows: the reporting person received one (1) share of Petros Common Stock for every five (5) shares of Neurotrope common stock held."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-132155","document":"tm2037705d7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920132155/tm2037705d7_4seq1.xml","form_type":"4"}},{"id":2965231,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-27T17:09:51.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC (\"Metuchen\"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (\"Petros\") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. (\"Neurotrope\"), with Neurotrope surviving as a wholly-owned subsidiary of Petros."}],"balance_after":40000,"derivative":{"exercise_price":0.972,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-130080","document":"tm2037145d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000110465920130080/tm2037145d7_4seq1.xml","form_type":"4"}},{"id":3688087,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T18:01:50.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was made pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan. The stock options shall vest according to the following schedule: 50% vest on the date of grant, with the remaining stock options vesting in equal quarterly installments over a two-year period following the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":3.93,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001144204-19-002683","document":"tv511523_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000114420419002683/tv511523_4.xml","form_type":"4"}},{"id":4352664,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2017-04-13T21:46:12.000Z","date":"2017-04-11","kind":"grant","acquired":true,"shares":167000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Such option grant is subject to stockholder approval of the Issuer's 2017 Equity Incentive Plan under which the option was granted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal quarterly installments over a three-year period."}],"balance_after":167000,"derivative":{"exercise_price":19.62,"expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":167000},"source":{"system":"sec-edgar","filing":"0001144204-17-020447","document":"v464203_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000114420417020447/v464203_4.xml","form_type":"4"}},{"id":4543208,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":121418,"kind":"person","name":"Alkon Daniel L.","position":1,"cik":"0001686138","reported_name":"Alkon Daniel L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2016-11-23T17:01:08.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":3976767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted in connection with the Issuer's grant to certain officers, directors and employees following the final closing of a private placement on November 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half of the stock options vest immediately upon grant and the remaining one half vest in equal daily installments over a four-year period beginning on the date of grant."}],"balance_after":3976767,"derivative":{"exercise_price":0.33,"expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":3976767},"source":{"system":"sec-edgar","filing":"0001144204-16-136403","document":"v453758_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686138/000114420416136403/v453758_4.xml","form_type":"4"}}]}